Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 1,079,050 | 1,079,050 | 0 | $76.67M | $76.49M | 26.45% | -$172.6K |
| Latigo Biotherapeutics, Inc. | 0 | 3,562,984 | +3,562,984 | $0 | $59.50M | 20.58% | +$59.50M |
| Alumis Inc. | 5,896,995 | 5,896,995 | 0 | $165.94M | $43.58M | 15.07% | -$122.36M |
| Hims & Hers Health, Inc.CL A(HIMS) | 738,151 | 883,751 | +145,600 | $25.59M | $26.33M | 9.11% | +$735.2K |
| Disc Medicine, Inc.(IRON) | 374,069 | 374,069 | 0 | $27.36M | $24.49M | 8.47% | -$2.87M |
| Pharvaris N.V. COM | 664,142 | 664,142 | 0 | $22.97M | $21.07M | 7.29% | -$1.90M |
| Odyssey Therapeutics, Inc. | 713,105 | 729,602 | +16,497 | $13.34M | $16.21M | 5.61% | +$2.87M |
| Nurix Therapeutics, Inc.(NRIX) | 265,000 | 458,742 | +193,742 | $6.43M | $10.88M | 3.76% | +$4.45M |
| Eikon Therapeutics, Inc.(EIKN) | 1,318,983 | 1,318,983 | 0 | $17.21M | $10.60M | 3.67% | -$6.61M |
| Lyell Immunopharma, Inc.(LYEL) | 476,386 | 0 | -476,386 | $6.69M | $0 | — | -$6.69M |